Literature DB >> 7595197

Fas ligation induces apoptosis of CD40-activated human B lymphocytes.

P Garrone1, E M Neidhardt, E Garcia, L Galibert, C van Kooten, J Banchereau.   

Abstract

Since CD40/CD40 ligand (CD40Lig) interactions are essential in vivo for the generation of germinal center B cells that express Fas (Apo-1/CD95), we explored whether CD40 engagement may modulate Fas expression and function on human B lymphocytes. Resting tonsil B cells, isolated by density gradient centrifugation, express either absent or low levels of Fas. They could be induced to promptly express Fas after ligation of their CD40, however, using either a recombinant human CD40Lig or a cross-linked anti-CD40 mAb. In contrast, engagement of the B cell antigen receptor by immobilized anti-kappa and -lambda antibodies did not turn on Fas expression. Addition of anti-Fas mAb CH11 inhibited the later phases of CD40-induced B cell growth as a result of apoptotic cell death. Furthermore, Fas ligation inhibited proliferation and Ig secretion of CD40-activated B cells in response to recombinant cytokines such as interleukin (IL)-2, IL-4, and IL-10, as well as a cytokine-rich supernatant of phytohemagglutinin-activated T cells, indicating that none of those B cell tropic factors were able to prevent the Fas-induced death. Taken together, the present results show that engagement of CD40 antigen on B cells induces Fas expression and sensitizes them to Fas-mediated apoptosis. The delayed functional response to Fas ligation after CD40 activation may represent a way to limit the size of a specific B cell clone that is generated during T-B cell interactions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7595197      PMCID: PMC2192208          DOI: 10.1084/jem.182.5.1265

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  57 in total

1.  Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood.

Authors:  T Miyawaki; T Uehara; R Nibu; T Tsuji; A Yachie; S Yonehara; N Taniguchi
Journal:  J Immunol       Date:  1992-12-01       Impact factor: 5.422

2.  Effect of bcl-2 on Fas antigen-mediated cell death.

Authors:  N Itoh; Y Tsujimoto; S Nagata
Journal:  J Immunol       Date:  1993-07-15       Impact factor: 5.422

3.  Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family.

Authors:  T Suda; T Takahashi; P Golstein; S Nagata
Journal:  Cell       Date:  1993-12-17       Impact factor: 41.582

Review 4.  Molecular regulation of apoptosis: genetic controls on cell death.

Authors:  G T Williams; C A Smith
Journal:  Cell       Date:  1993-09-10       Impact factor: 41.582

5.  APO-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: correlation with bcl-2 oncogene expression.

Authors:  M Y Mapara; R Bargou; C Zugck; H Döhner; F Ustaoglu; R R Jonker; P H Krammer; B Dörken
Journal:  Eur J Immunol       Date:  1993-03       Impact factor: 5.532

6.  Coregulation of the APO-1 antigen with intercellular adhesion molecule-1 (CD54) in tonsillar B cells and coordinate expression in follicular center B cells and in follicle center and mediastinal B-cell lymphomas.

Authors:  P Möller; C Henne; F Leithäuser; A Eichelmann; A Schmidt; S Brüderlein; J Dhein; P H Krammer
Journal:  Blood       Date:  1993-04-15       Impact factor: 22.113

7.  IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand.

Authors:  B G Cocks; R de Waal Malefyt; J P Galizzi; J E de Vries; G Aversa
Journal:  Int Immunol       Date:  1993-06       Impact factor: 4.823

8.  Activation interferes with the APO-1 pathway in mature human T cells.

Authors:  C Klas; K M Debatin; R R Jonker; P H Krammer
Journal:  Int Immunol       Date:  1993-06       Impact factor: 4.823

9.  Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity.

Authors:  E Rouvier; M F Luciani; P Golstein
Journal:  J Exp Med       Date:  1993-01-01       Impact factor: 14.307

10.  Interleukin 10 (IL-10) upregulates functional high affinity IL-2 receptors on normal and leukemic B lymphocytes.

Authors:  A C Fluckiger; P Garrone; I Durand; J P Galizzi; J Banchereau
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

View more
  74 in total

Review 1.  Fortifying B cells with CD154: an engaging tale of many hues.

Authors:  J Gordon; J D Pound
Journal:  Immunology       Date:  2000-07       Impact factor: 7.397

2.  Pseudovirion particles bearing native HIV envelope trimers facilitate a novel method for generating human neutralizing monoclonal antibodies against HIV.

Authors:  Mark D Hicar; Xuemin Chen; Bryan Briney; Jason Hammonds; Jaang-Jiun Wang; Spyros Kalams; Paul W Spearman; James E Crowe
Journal:  J Acquir Immune Defic Syndr       Date:  2010-07       Impact factor: 3.731

3.  B lymphocytes are resistant to death receptor 5-induced apoptosis.

Authors:  Roslyn N Crowder; Hong Zhao; W Winn Chatham; Tong Zhou; Robert H Carter
Journal:  Clin Immunol       Date:  2011-01-28       Impact factor: 3.969

4.  Precursor B cells for autoantibody production in genomically Fas-intact autoimmune disease are not subject to Fas-mediated immune elimination.

Authors:  S Hirose; K Yan; M Abe; Y Jiang; Y Hamano; H Tsurui; T Shirai
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

5.  Spleen tyrosine kinase inhibitors reduce CD40L-induced proliferation of chronic lymphocytic leukemia cells but not normal B cells.

Authors:  Anna Parente-Ribes; Sigrid S Skånland; Simone Bürgler; Audun Os; Dong Wang; Bjarne Bogen; Geir E Tjønnfjord; Kjetil Taskén; Ludvig A Munthe
Journal:  Haematologica       Date:  2015-11-20       Impact factor: 9.941

6.  Tumoricidal effects of activated macrophages in a mouse model of chronic lymphocytic leukemia.

Authors:  Qing-Li Wu; Ilia N Buhtoiarov; Paul M Sondel; Alexander L Rakhmilevich; Erik A Ranheim
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

Review 7.  The ITP syndrome: pathogenic and clinical diversity.

Authors:  Douglas B Cines; James B Bussel; Howard A Liebman; Eline T Luning Prak
Journal:  Blood       Date:  2009-04-24       Impact factor: 22.113

8.  Potential role of soluble CD40 in the humoral immune response impairment of uraemic patients.

Authors:  Cécile Contin; Vincent Pitard; Yahsou Delmas; Nadège Pelletier; Thierry Defrance; Jean-François Moreau; Pierre Merville; Julie Déchanet-Merville
Journal:  Immunology       Date:  2003-09       Impact factor: 7.397

9.  Natural antibodies sustain differentiation and maturation of human dendritic cells.

Authors:  Jagadeesh Bayry; Sébastien Lacroix-Desmazes; Vladimira Donkova-Petrini; Cédric Carbonneil; Namita Misra; Yves Lepelletier; Sandrine Delignat; Sooryanarayana Varambally; Eric Oksenhendler; Yves Lévy; Marianne Debré; Michel D Kazatchkine; Olivier Hermine; Srini V Kaveri
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-20       Impact factor: 11.205

10.  Production of inflammatory mediators by renal epithelial cells is insensitive to glucocorticoids.

Authors:  Simone de Haij; Andrea M Woltman; Astrid C Bakker; Mohamed R Daha; Cees van Kooten
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.